☆ 4.7 Review

The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer

JOURNAL OF PERSONALIZED MEDICINE (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

miR-126 regulates the proliferation, migration, invasion, and apoptosis of non-small lung cancer cells via AKT2/HK2 axis

Bin Huang et al.

Summary: This study aimed to clarify the role of miR-126 in the biological behaviors of non-small cell lung cancer (NSCLC) cells, including cell proliferation, migration, invasion, and apoptosis. The results showed that miR-126 was significantly down-regulated in NSCLC, and overexpression of miR-126 inhibited cell proliferation, migration, and invasion while promoting cell apoptosis.

IUBMB LIFE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway

Saba Hashemi et al.

Summary: MiRNA-377 functions as a tumor suppressor in NSCLC by targeting EGFR, MAPK1, and PAK2 genes, reducing proliferation and inducing apoptosis in lung cancer cells. This suggests that miRNA-377 may serve as a potential therapeutic target for NSCLC treatment.

MOLECULAR BIOLOGY REPORTS (2022)

Add to Collection

Article Oncology

miR-129-2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4

Weizheng Zhou et al.

Summary: miR-129-2 plays a significant role in non-small-cell lung cancer (NSCLC) by inducing cell apoptosis and promoting chemosensitivity.

THORACIC CANCER (2022)

Add to Collection

Article Oncology

Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma

Xiulin Jiang et al.

Summary: The expression of miRNA-30a-5p is significantly decreased in LUAD and is associated with clinical outcomes and immune cell infiltration. Furthermore, miRNA-30a-5p has been found to inhibit cell proliferation and migration in LUAD.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor

Emad A. Ahmed et al.

Summary: MicroRNA-202 (miR-202), a member of the let-7 family, plays a crucial role in cell differentiation and tumor biology. Its dysregulation has been observed in various types of cancer, where it can have both tumor suppressive and oncogenic effects. miR-202 shows potential as a diagnostic biomarker and a suppressor of tumorigenesis and metastasis in different cancers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Oncology

The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility

Weipeng Liu et al.

Summary: The expression of EGFL7 and miR-126 is downregulated in non-small cell lung cancer (NSCLC) through methylation. The EGFL7/miR-126 polymorphism rs2297538 is associated with NSCLC risk.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer

A. S. Pal et al.

Summary: Lung cancer is a major cause of cancer-related deaths, and overcoming resistance to EGFR inhibitors is crucial in the treatment of non-small cell lung cancer. This study identifies the important role of microRNAs in driving resistance to EGFR inhibitors in non-small cell lung cancer cells.

BIOCHEMICAL PHARMACOLOGY (2021)

Add to Collection

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Oncology

Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC

Simon Garinet et al.

Summary: EMT score is not predictive of outcome in NSCLC patients after surgery. miR-200a, b, and 429 are associated with disease-free survival and overall survival in NSCLC patients. MiR profiling may have important clinical value in identifying prognostic groups.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer

Xiaohan Dong et al.

Summary: The study indicates that high expression of miR-1247-5p, miR-301b-3p, and miR-105-5p can accelerate the tumorigenesis of NSCLC, and these three miRNAs in plasma serve as novel biomarkers for early diagnosis of NSCLC patients.

THORACIC CANCER (2021)

Add to Collection

Article Oncology

Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients

Yao Wu et al.

Summary: This study aimed to investigate the potential risk of circulating HPV-DNA in NSCLC and analyze the abnormally expressed miRNAs in circulating HPV-DNA-positive NSCLC. Circulating HPV-DNA was found in 16 NSCLC patients, with higher levels of miR-183, miR-210, and miR-182, and lower levels of miR-144 compared to HPV-DNA-negative patients. Using miR-210 had the highest AUC for identifying circulating HPV-DNA-positive NSCLC patients, and the combination of miR-210 and miR-144 showed the best predictive performance. These findings suggest that circulating HPV-DNA could be a risk factor in NSCLC, and plasma miR-183, miR-210, miR-182, and miR-144 can be reliable biomarkers for identifying circulating HPV-DNA-positive NSCLC.

CANCER BIOLOGY & THERAPY (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Upregulation of Serum m R-629 Predicts Poor Prognosis for NonSmall-Cell Lung Cancer

Fayong Liu et al.

Summary: Serum miR-629 may serve as a potential prognostic biomarker for NSCLC, as its expression is correlated with patient outcomes and can discriminate NSCLC patients from healthy controls more effectively than traditional biomarkers.

DISEASE MARKERS (2021)

Add to Collection

Article Medical Laboratory Technology

Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer

Junbo Xia et al.

Summary: Through extensive analysis of exosomal miRNA from EGFR mutation and wild-type NSCLC patients, the study identified 96 significantly different expressed miRNAs, with 39 upregulated and 57 downregulated. Specific miRNAs were found to distinguish between early-stage mutant EGFR and wild-type NSCLC patients.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)

Add to Collection

Article Oncology

Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients

Anna Grenda et al.

Summary: miR-200b and miR-429 molecules in tumor cells appear to have the greatest impact on the effectiveness of immunotherapy in NSCLC patients. There is a significant correlation between the expression levels of these two microRNAs and the effectiveness of immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer

Monika Migdalska-Sek et al.

Summary: The study found that the expressions of PPAR delta and miR-17 were significantly lower in NSCLC patients compared to the control group, showing potential diagnostic value in distinguishing NSCLC from controls. Additionally, differences in expression were observed in different subgroups, indicating potential roles in early diagnosis and differentiation of NSCLC histotypes.

SCIENTIFIC REPORTS (2021)

Add to Collection

Review Medicine, General & Internal

Clinico-Pathological Importance of miR-146a in Lung Cancer

Javaid Ahmad Wani et al.

Summary: miR-146a is a crucial modulator of the innate immune response and has been shown to play a key role in various cancers. It suppresses tumor proliferation and metastasis in lung cancer and has potential as a diagnostic marker for the disease.

DIAGNOSTICS (2021)

Add to Collection

Article Oncology

Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients

Keatdamrong Janpipatkul et al.

Summary: In this study, the profile of exosomal miRNA in osimertinib-resistant NSCLC patients was analyzed, showing 10 significantly dysregulated exosomal miRNAs. The upregulation of these miRNAs correlated with increased latency to treatment failure and improved overall survival. Among them, miR-323-3p, miR-1468-3p, miR-5189-5p, and miR-6513-5p were identified as potential markers for discriminating osimertinib-resistant from osimertinib-sensitive NSCLC patients.

CANCER BIOMARKERS (2021)

Add to Collection

Article Oncology

MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX1

Tongqing Xue et al.

Summary: MiR-129-5p sensitizes A549-R and H1299-R cells to radiation by targeting RUNX1 and SOX4, inducing cell apoptosis, DNA injury, cell cycle arrest, and inhibiting cell proliferation and colony formation.

CURRENT CANCER DRUG TARGETS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer

Shimaa El-Shafey Soliman et al.

Summary: miR-21-5p and miR-126-3p play important roles in diagnosis and prognosis, potentially serving as valuable biomarkers for non-small cell lung cancer patients.

MOLECULAR BIOLOGY REPORTS (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9

Bo Liu et al.

Summary: The study revealed that miR-126-5p was downregulated while ADAM9 was upregulated in NSCLC, and negatively regulating ADAM9 could increase the sensitivity of NSCLC to cisplatin.

BIOMED RESEARCH INTERNATIONAL (2021)

Add to Collection

Article Cell Biology

Micro-RNA: The darkhorse of cancer

Mridul Budakoti et al.

Summary: The discovery of micro RNAs in cancer has provided new insights for researchers in understanding their role as master regulators in controlling gene expression during various cellular processes, making them potential targets for cancer therapeutics.

CELLULAR SIGNALLING (2021)

Add to Collection

Review Pathology

The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis

Hairong Huang et al.

Summary: In this meta-analysis, extracellular vesicles (EV) miRNAs showed high diagnostic accuracy for non-small cell lung cancer (NSCLC) with an AUC of 0.86. Certain EV miRNAs were able to distinguish metastatic and early-stage NSCLC, with miR-21, miR-210, and miR-1290 potentially activating the PI3K/AKT-related pathway and serving as valuable diagnostic biomarkers for NSCLC. Combination of multiple EV miRNAs demonstrated higher diagnostic value compared to single miRNAs.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data

Qing Ye et al.

Summary: A novel methodology was developed to correlate miRNA expression profiles with tumor progression and chemosensitivity in lung cancer. Hsa-miR-142-3p was identified as a miRNA associated with good prognosis and chemosensitivity in lung cancer patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Medicine, Research & Experimental

Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis

Zhiyu Song et al.

Summary: The study revealed the role of exosomal miRNA miR-4443 in controlling cisplatin resistance in NSCLC, showing that miR-4443 confers cisplatin resistance by transferring through exosomes and enhances tumor growth by regulating the FSP1-mediated ferroptosis pathway. Additionally, METTL3 was identified as a direct target gene of miR-4443, providing insights into the therapeutic potential of targeting ferroptosis in NSCLC chemoresistance.

LIFE SCIENCES (2021)

Add to Collection

Article Oncology

Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling

Daniela Di Paolo et al.

Summary: Simultaneously targeting miR-126-3p and miR-221-3p to inhibit tumor growth and metastasis could be a novel therapeutic approach for lung cancer management.

MOLECULAR ONCOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Knockdown of miR-15b partially reverses the cisplatin resistance of NSCLC through the GSK-3β/MCL-1 pathway

Tianjian Lu et al.

Summary: This study investigated the functional role of miR-15b in cisplatin resistance in non-small cell lung cancer (NSCLC). Overexpression of miR-15b was found in cisplatin-resistant NSCLC cells, and knockdown of miR-15b reversed cisplatin resistance through the GSK-3 beta/MCL-1 pathway.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2021)

Add to Collection

Article Cell Biology

A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer

Alexia Monastirioti et al.

Summary: The study revealed that high expression of miR-202 in non-small cell lung cancer patients is associated with disease progression, shorter progression-free survival, and overall survival. In subgroup analysis, miR-202 and miR-26a expression had different impacts on overall survival in squamous and non-squamous subgroups. These findings suggest that circulating miRNAs may serve as potential biomarkers in NSCLC patients.

CELLS (2021)

Add to Collection

Article Cell Biology

Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs

Alessandro Leonetti et al.

Summary: Our study found that patients with an increase in miR-21 levels after two months of EGFR-TKI treatment were more likely to experience disease stability/progression. Patients who experienced clinical benefit lasting at least six months showed higher levels of circulating miR-21.

CELLS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy

Yuanyuan Liang et al.

Summary: MicroRNAs, specifically the miR-320 family, play a crucial role in regulating gene expression and have been identified as tumor suppressors. Their functions in cancer research extend to inhibition of epithelial-mesenchymal transition, cell proliferation, and apoptosis, while also serving as potential biomarkers for cancer diagnosis and prognosis.

BIOMEDICINES (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death

Feng Shi et al.

Summary: miR-556-5p, upregulated in cisplatin-resistant NSCLC patients, suppresses cisplatin-sensitivity by inducing NLRP3-mediated pyroptotic cell death. This finding offers new therapeutic strategies to overcome chemo-resistance in NSCLC patients.

BIOENGINEERED (2021)

Add to Collection

Article Biotechnology & Applied Microbiology

MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route

Butong Sun et al.

Summary: The research found that miR-25-3p plays a crucial role in cisplatin resistance in NSCLC, accelerating drug tolerance by regulating the PTEN/PI3K/AKT signaling pathway.

BIOENGINEERED (2021)

Add to Collection

Article Oncology

MiR-30a sensitized lung cancer against neoadjuvant chemotherapy by depressing autophagy

Xiao Lin et al.

Summary: The study found that the low expression of miR-30a was closely related to malignant pathological characteristics and prognosis in NSCLC patients after neoadjuvant chemotherapy. Up-regulation of miR-30a can reduce the resistance of NSCLC cells to chemotherapy drugs, suppress chemotherapy-induced autophagy, and promote cell apoptosis.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2

Ke-Gang Jia et al.

JOURNAL OF BIOCHEMISTRY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses

Feifeng Song et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Micro(RNA) Management and Mismanagement of the Islet

Lena Eliasson et al.

JOURNAL OF MOLECULAR BIOLOGY (2020)

Add to Collection

Article Genetics & Heredity

MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

Li Gao et al.

BMC MEDICAL GENOMICS (2020)

Add to Collection

Article Cell Biology

miR-29b inhibits non-small cell lung cancer progression by targeting STRN4

Yuping Xie et al.

HUMAN CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer

Lin Sun et al.

BIOSCIENCE REPORTS (2020)

Add to Collection

Article Oncology

Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer

Xiang Jin et al.

BMC CANCER (2020)

Add to Collection

Article Biochemistry & Molecular Biology

MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C

Ming Liao et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2020)

Add to Collection

Article Medical Laboratory Technology

Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer

Ning Wang et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

MicroRNA-92b acts as an oncogene by targetingPTEN/AKTinNSCLC

Jia-Hui Guo et al.

CELL BIOCHEMISTRY AND FUNCTION (2020)

Add to Collection

Article Medical Laboratory Technology

A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer

Chengwei Zhou et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Add to Collection

Article Medicine, Research & Experimental

Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer

Xueying Cai et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

Development of a serum miRNA panel for detection of early stage non-small cell lung cancer

Lisha Ying et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Oncology

Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6

Mingjun Li et al.

CANCER CELL INTERNATIONAL (2020)

Add to Collection

Article

miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells

Nicholas J. Monteleone et al.

Oncotarget (2020)

Add to Collection

Article Oncology

Bioinformatics analysis to determine the prognostic value and prospective pathway signaling of miR-126 in non-small cell lung cancer

Zichen Jiao et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

The role of monoamine oxidase A in HPV-16 E7-induced epithelial-mesenchymal transition and HIF-1α protein accumulation in non-small cell lung cancer cells

Bingyu Huang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Add to Collection

Article Oncology

MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway

Lin Zhu et al.

CANCER BIOMARKERS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy

Alexandru Tirpe et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Oncology

被撤回的出版物: Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer (Retracted article. See vol. 30, 2023)

Hao Ding et al.

CANCER CONTROL (2020)

Add to Collection

Article Multidisciplinary Sciences

Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer

Pichitpon Chaniad et al.

PLOS ONE (2020)

Add to Collection

Review Respiratory System

Update 2020: Management of Non-Small Cell Lung Cancer

Mariam Alexander et al.

LUNG (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer

Huifang Nie et al.

NANOSCALE (2020)

Add to Collection

Article Multidisciplinary Sciences

MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer

Qiao Zhang et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Review Immunology

The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression

Sook Shien Lee et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2019)

Add to Collection

Article Medical Laboratory Technology

Clinical significance of serum miR-25 in non-small-cell lung cancer

J. Li et al.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2019)

Add to Collection

Article Oncology

Tumor suppressor function of miR-129-5p in lung cancer

Ge Li et al.

ONCOLOGY LETTERS (2019)

Add to Collection

Article Cell Biology

miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway

Tangwei Wu et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Add to Collection

Article Medicine, Research & Experimental

MicroRNA-191 targets CCAAT/enhanced binding protein β and functions as an oncogenic molecule in human non-small cell lung carcinoma cells

Fuliang Li et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)

Add to Collection

Review Medicine, General & Internal

Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Narjust Duma et al.

MAYO CLINIC PROCEEDINGS (2019)

Add to Collection

Article Oncology

Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients

Cherylle Goebel et al.

CANCER GENOMICS & PROTEOMICS (2019)

Add to Collection

Review Oncology

Update on Immunohistochemistry for the Diagnosis of Lung Cancer

Kentaro Inamura

CANCERS (2018)

Add to Collection

Review Oncology

Roles of miR-200 family members in lung cancer: more than tumor suppressors

Cong Liu et al.

FUTURE ONCOLOGY (2018)

Add to Collection

Article Respiratory System

The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism

Cao Bin et al.

EXPERIMENTAL LUNG RESEARCH (2018)

Add to Collection

Article Oncology

miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer

M. Kang et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2018)

Add to Collection

Article Pharmacology & Pharmacy

miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells

Weihua Zhang et al.

JOURNAL OF DRUG TARGETING (2017)

Add to Collection

Article Oncology

miRNA-375 regulates the cell survival and apoptosis of human non-small cell carcinoma by targeting HER2

Longqiang Cheng et al.

MOLECULAR MEDICINE REPORTS (2017)

Add to Collection

Article Oncology

被撤回的出版物: miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3 (Retracted article. See vol. 26, 2022)

Zhonghai Zhao et al.

MOLECULAR MEDICINE REPORTS (2017)

Add to Collection

Article Oncology

Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection

Maria Sromek et al.

CELLULAR ONCOLOGY (2017)

Add to Collection

Review Biochemistry & Molecular Biology

Progress and prospects of early detection in lung cancer

Sean Blandin Knight et al.

OPEN BIOLOGY (2017)

Add to Collection

Review Oncology

Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies

Michael Yousef et al.

CANCERS (2017)

Add to Collection

Article Multidisciplinary Sciences

The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases

Akiteru Goto et al.

PLOS ONE (2017)

Add to Collection

Article Cell Biology

MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2

Jing Chen et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Add to Collection

Article Oncology

Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma

Laura Boldrini et al.

CANCER CELL INTERNATIONAL (2017)

Add to Collection

Article Oncology

Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing

Xiance Jin et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Medicine, Research & Experimental

miR-98 inhibits expression of TWIST to prevent progression of non-small cell lung cancers

Haiyu Zhou et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Add to Collection

Article Oncology

MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase

Ting Lei et al.

MOLECULAR MEDICINE REPORTS (2016)

Add to Collection

Article Biochemistry & Molecular Biology

miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression

Zhiwei He et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Add to Collection

Article Oncology

Inhibition of miR-191 contributes to radiation-resistance of two lung cancer cell lines by altering autophagy activity

Zhenkuan Liu et al.

CANCER CELL INTERNATIONAL (2015)

Add to Collection

Article Chemistry, Medicinal

The Role of miR-21 in Cancer

Susan R. Pfeffer et al.

DRUG DEVELOPMENT RESEARCH (2015)

Add to Collection

Review Oncology

The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification

William D. Travis et al.

JOURNAL OF THORACIC ONCOLOGY (2015)

Add to Collection

Article Oncology

Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry

Florian Kocher et al.

LUNG CANCER (2015)

Add to Collection

Article Oncology

被撤回的出版物: miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo (Retracted article. See vol. 49, 2023)

Xingyu Lin et al.

ONCOLOGY REPORTS (2015)

Add to Collection

Article Multidisciplinary Sciences

Oncogenic miR-9 is a target of erlotinib in NSCLCs

Xi Chen et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Biochemistry & Molecular Biology

miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy

Fang Wang et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2015)

Add to Collection

Article Cell Biology

miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14

Ning Wu et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC

Yang Xia et al.

FEBS LETTERS (2014)

Add to Collection

Article Genetics & Heredity

Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer

Hong Yu et al.

GENE (2014)

Add to Collection

Article Medical Laboratory Technology

Large cell carcinoma of lung: On the verge of extinction?

Annikka Weissferdt

SEMINARS IN DIAGNOSTIC PATHOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

MiR-200c Increases the Radiosensitivity of Non-Small-Cell Lung Cancer Cell Line A549 by Targeting VEGF-VEGFR2 Pathway

Liangliang Shi et al.

PLOS ONE (2013)

Add to Collection

Article Oncology

Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

Jin Sung Jang et al.

CLINICAL CANCER RESEARCH (2012)

Add to Collection

Article Medicine, Research & Experimental

Decreased Expression of MicroRNA-375 in Nonsmall Cell Lung Cancer and its Clinical Significance

Y. Li et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Lung Cancer Epidemiology, Risk Factors, and Prevention

Patricia de Groot et al.

RADIOLOGIC CLINICS OF NORTH AMERICA (2012)

Add to Collection

Article Medicine, Research & Experimental

Sputum MicroRNA Profiling: A Novel Approach for the Early Detection of Non-Small Cell Lung Cancer

Wilson H. Roa et al.

CLINICAL AND INVESTIGATIVE MEDICINE (2012)

Add to Collection

Article Oncology

Prognostic Implications of miR-16 Expression Levels in Resected Non-Small-Cell Lung Cancer

Alfons Navarro et al.

JOURNAL OF SURGICAL ONCOLOGY (2011)

Add to Collection

Article Oncology

MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer

Maria Teresa Landi et al.

CLINICAL CANCER RESEARCH (2010)

Add to Collection

Review Biology

Circulating miRNA and cancer diagnosis

Tie Yi et al.

SCIENCE IN CHINA SERIES C-LIFE SCIENCES (2009)

Add to Collection

Article Multidisciplinary Sciences

Serum MicroRNAs Are Promising Novel Biomarkers

Shlomit Gilad et al.

PLOS ONE (2008)

Add to Collection

Review Cell Biology

The let-7 family of microRNAs

Sarah Roush et al.

TRENDS IN CELL BIOLOGY (2008)

Add to Collection

Review Oncology

Lung cancer in never smokers - a different disease

Sophie Sun et al.

NATURE REVIEWS CANCER (2007)

Add to Collection

Article Oncology

RNAi, microRNAs, and human disease

Scott M. Hammond

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.